{"id":"2-benzhydryloxyethyldiethyl-methylammonium-iodide","rwe":[],"tags":[{"label":"(2-benzhydryloxyethyl)diethyl-methylammonium iodide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A03AB16","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"esyntin","offLabel":[],"synonyms":["emetonium iodide","emetonium","(2-benzhydryloxyethyl)diethyl-methylammonium iodide","ethylbenzhydramine methyl iodide","esyntin","metropin"],"timeline":[],"brandName":"Esyntin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"(2-benzhydryloxyethyl)diethyl-methylammonium iodide","explanation":"Think of Esyntin like a key that fits into a lock. The key (Esyntin) binds to a specific lock (biological molecule) to turn it on or off, which can help to treat a particular disease or condition. This binding process is what allows Esyntin to produce its therapeutic effect.","oneSentence":"Esyntin works by binding to specific biological molecules to produce a therapeutic effect.","technicalDetail":"Esyntin's mechanism of action is likely to involve the interaction with a specific receptor or enzyme, which triggers a downstream signaling cascade to produce its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4327","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=(2-benzhydryloxyethyl)diethyl-methylammonium iodide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T07:24:08.775735","biosimilars":[],"competitors":[{"drugName":"glycopyrronium bromide","drugSlug":"glycopyrronium-bromide","fdaApproval":"1961-08-11","relationship":"same-class"},{"drugName":"oxyphenonium","drugSlug":"oxyphenonium","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"propantheline","drugSlug":"propantheline","fdaApproval":"1953-04-02","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"methanthelinium","drugSlug":"methanthelinium","fdaApproval":"1951-07-03","relationship":"same-class"},{"drugName":"tridihexethyl","drugSlug":"tridihexethyl","fdaApproval":"1954-09-15","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"isopropamide","drugSlug":"isopropamide","fdaApproval":"1957-10-09","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"hexocyclium","drugSlug":"hexocyclium","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"mepenzolate","drugSlug":"mepenzolate","fdaApproval":"1956-11-14","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"diphemanil","drugSlug":"diphemanil","fdaApproval":"1976-05-17","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"(2-benzhydryloxyethyl)diethyl-methylammonium iodide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"glycopyrronium-bromide","brandName":"glycopyrronium bromide","genericName":"glycopyrronium bromide","approvalYear":"1961","relationship":"same-class"},{"drugId":"oxyphenonium","brandName":"oxyphenonium","genericName":"oxyphenonium","approvalYear":"","relationship":"same-class"},{"drugId":"propantheline","brandName":"propantheline","genericName":"propantheline","approvalYear":"1953","relationship":"same-class"},{"drugId":"methanthelinium","brandName":"methanthelinium","genericName":"methanthelinium","approvalYear":"1951","relationship":"same-class"},{"drugId":"tridihexethyl","brandName":"tridihexethyl","genericName":"tridihexethyl","approvalYear":"1954","relationship":"same-class"},{"drugId":"isopropamide","brandName":"isopropamide","genericName":"isopropamide","approvalYear":"1957","relationship":"same-class"},{"drugId":"hexocyclium","brandName":"hexocyclium","genericName":"hexocyclium","approvalYear":"","relationship":"same-class"},{"drugId":"mepenzolate","brandName":"mepenzolate","genericName":"mepenzolate","approvalYear":"1956","relationship":"same-class"},{"drugId":"diphemanil","brandName":"diphemanil","genericName":"diphemanil","approvalYear":"1976","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"CW3OT0Y51W","CHEBI":"CHEBI:135943","UMLSCUI":"C3652946","ChEMBL_ID":"CHEMBL3707204","DRUGBANK_ID":"DB13769","PUBCHEM_CID":"80084","SECONDARY_CAS_RN":"19213-48-0"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A03AB16","allCodes":["A03AB16"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Esyntin, also known as (2-benzhydryloxyethyl)diethyl-methylammonium iodide, is a small molecule drug of unknown target and class. Its commercial status and approved indications are currently unknown. As a small molecule, Esyntin is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand Esyntin's properties and potential uses.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}